VUITY™, a new eye drop that hit stores on Thursday, December 9th, is the first FDA-approved eye medication for the treatment of presbyopia. The medication works by reducing the size of the pupil, which helps to expand the depth of focus and allows users to see at a range of distances.
VUITY™ can help people with mild to moderate presbyopia see close up without the use of glasses, but researchers warn that it should not be seen as a cure-all. Best for people under the age of 65, VUITY™ may not be useful in low light conditions or when driving at night. It also comes with potential side effects including headaches and dry eyes.
Presbyopia is an age-related vision condition that impacts a person’s ability to see objects close up. The condition occurs when the natural lens of the eye begins to harden, an unavoidable part of the aging process that typically begins to impact vision after age 40. VUITY™ has shown to be especially effective in people who are between the ages of 44 and 55, when the condition is in its earliest stages.
While unavoidable, presbyopia plateaus, meaning it will not result in a complete loss of vision. It can, however, necessitate reading glasses. As time progresses, it may even require prescription eyewear, though this is not the case for everyone.
Eyeglasses can be worn as needed, but are not the best solution for every patient. Options such as lens implants and certain types of LASIK may help reduce dependency on glasses for some people with presbyopia, but surgical options are not ideal for every need either. As a new treatment method, presbyopia eye drops may serve as an in-between option for those looking to lower their dependency on glasses but not interested in vision correction surgery.
We Can Help You Find the Best Solution
If you have begun to notice your near vision is diminishing and you are over the age of 40, give us a call at 845-454-1025 to schedule a presbyopia treatment evaluation today. We have offices in Fishkill and Poughkeepsie. We serve people living in all surrounding areas of New York.